{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:37Z","timestamp":1792790557122,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Military Infectious Disease Research Program"},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI151006"],"award-info":[{"award-number":["R01AI151006"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI151006-03S1"],"award-info":[{"award-number":["R01AI151006-03S1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI151006"],"award-info":[{"award-number":["R01AI151006"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000774","name":"United States Department of Defense | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA12210007"],"award-info":[{"award-number":["HDTRA12210007"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"United States Department of Defense | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA12210007"],"award-info":[{"award-number":["HDTRA12210007"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Crimean-Congo Hemorrhagic Fever Virus (CCHFV) causes a life-threatening disease with up to a 40% mortality rate. With no approved medical countermeasures, CCHFV is considered a public health priority agent. The non-neutralizing mouse monoclonal antibody (mAb) 13G8 targets CCHFV glycoprotein GP38 and protects mice from lethal CCHFV challenge when administered prophylactically or therapeutically. Here, we reveal the structures of GP38 bound with a human chimeric 13G8 mAb and a newly isolated CC5-17 mAb from a human survivor. These mAbs bind overlapping epitopes with a shifted angle. The broad-spectrum potential of c13G8 and CC5-17 and the practicality of using them against Aigai virus, a closely related nairovirus were examined. Binding studies demonstrate that the presence of non-conserved amino acids in Aigai virus corresponding region prevent CCHFV mAbs from binding Aigai virus GP38. This information, coupled with in vivo efficacy, paves the way for future mAb therapeutics effective against a wide swath of CCHFV strains.<\/jats:p>","DOI":"10.1038\/s41467-022-34923-0","type":"journal-article","created":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T20:25:02Z","timestamp":1669494302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus"],"prefix":"10.1038","volume":"13","author":[{"given":"Ian A.","family":"Durie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-1290","authenticated-orcid":false,"given":"Zahra R.","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Karaaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-4040","authenticated-orcid":false,"given":"Teresa E.","family":"Sorvillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-313X","authenticated-orcid":false,"given":"Joseph W.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6905-8521","authenticated-orcid":false,"given":"Stephen R.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2492-1210","authenticated-orcid":false,"given":"Markus H.","family":"Kainulainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-0254","authenticated-orcid":false,"given":"Jessica R.","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4709-2478","authenticated-orcid":false,"given":"Jarrod J.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Enos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftihar","family":"Koksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdal","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanife Nur","family":"Karakoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Albay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-0513","authenticated-orcid":false,"given":"Jessica R.","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-6400","authenticated-orcid":false,"given":"Aura R.","family":"Garrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Sajadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-8628","authenticated-orcid":false,"given":"\u00c9ric","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2958-5319","authenticated-orcid":false,"given":"Scott D.","family":"Pegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"34923_CR1","first-page":"82","volume":"58","author":"SS Al-Abri","year":"2017","unstructured":"Al-Abri, S. S. et al. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis. 58, 82\u201389 (2017).","journal-title":"Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis."},{"key":"34923_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.coviro.2018.12.002","volume":"34","author":"JR Spengler","year":"2019","unstructured":"Spengler, J. R., Bergeron, \u00c9. & Spiropoulou, C. F. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Curr. Opin. Virol. 34, 70\u201378 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"34923_CR3","doi-asserted-by":"publisher","unstructured":"Papa, A. et al. History and classification of Aigai virus (formerly Crimean-Congo haemorrhagic fever virus genotype VI). J. Gen. Virol. https:\/\/doi.org\/10.1099\/jgv.0.001734 (2022).","DOI":"10.1099\/jgv.0.001734"},{"key":"34923_CR4","doi-asserted-by":"publisher","first-page":"8834","DOI":"10.1128\/JVI.00752-06","volume":"80","author":"VM Deyde","year":"2006","unstructured":"Deyde, V. M., Khristova, M. L., Rollin, P. E., Ksiazek, T. G. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. 80, 8834\u20138842 (2006).","journal-title":"J. Virol."},{"key":"34923_CR5","doi-asserted-by":"publisher","first-page":"13271","DOI":"10.1128\/JVI.01647-07","volume":"81","author":"E Bergeron","year":"2007","unstructured":"Bergeron, E., Vincent, M. J. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1\/S1P is critical for virus infectivity. J. Virol. 81, 13271\u201313276 (2007).","journal-title":"J. Virol."},{"key":"34923_CR6","doi-asserted-by":"publisher","unstructured":"Zivcec, M., Scholte, F. E. M., Spiropoulou, C. F., Spengler, J. R. & Bergeron, \u00c9. Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus. Viruses 8 https:\/\/doi.org\/10.3390\/v8040106 (2016).","DOI":"10.3390\/v8040106"},{"key":"34923_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/21645515.2015.1078045","volume":"12","author":"SD Dowall","year":"2016","unstructured":"Dowall, S. D. et al. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Hum. Vaccines Immunother. 12, 519\u2013527 (2016).","journal-title":"Hum. Vaccines Immunother."},{"key":"34923_CR8","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1016\/j.vaccine.2017.05.031","volume":"35","author":"SD Dowall","year":"2017","unstructured":"Dowall, S. D., Carroll, M. W. & Hewson, R. Development of vaccines against Crimean-Congo haemorrhagic fever virus. Vaccine 35, 6015\u20136023 (2017).","journal-title":"Vaccine"},{"key":"34923_CR9","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","volume":"184","author":"JM Fels","year":"2021","unstructured":"Fels, J. M. et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell 184, 3486\u20133501.e3421 (2021).","journal-title":"Cell"},{"key":"34923_CR10","doi-asserted-by":"publisher","first-page":"e0005908","DOI":"10.1371\/journal.pntd.0005908","volume":"11","author":"AR Garrison","year":"2017","unstructured":"Garrison, A. R. et al. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. PLOS Neglected Tropical Dis. 11, e0005908 (2017).","journal-title":"PLOS Neglected Tropical Dis."},{"key":"34923_CR11","doi-asserted-by":"publisher","first-page":"eaaw9535","DOI":"10.1126\/sciadv.aaw9535","volume":"5","author":"JW Golden","year":"2019","unstructured":"Golden, J. W. et al. GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. Sci. Adv. 5, eaaw9535 (2019).","journal-title":"Sci. Adv."},{"key":"34923_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","volume":"6","author":"DW Hawman","year":"2021","unstructured":"Hawman, D. W. et al. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model. Nat. Microbiol. 6, 187\u2013195 (2021).","journal-title":"Nat. Microbiol."},{"key":"34923_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/22221751.2019.1601030","volume":"8","author":"FEM Scholte","year":"2019","unstructured":"Scholte, F. E. M. et al. Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice. Emerg. Microbes Infect. 8, 575\u2013578 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"34923_CR14","doi-asserted-by":"publisher","unstructured":"Guardado-Calvo, P. & Rey, F. A. The Viral Class II Membrane Fusion Machinery: Divergent Evolution from an Ancestral Heterodimer. Viruses 13 https:\/\/doi.org\/10.3390\/v13122368 (2021).","DOI":"10.3390\/v13122368"},{"key":"34923_CR15","doi-asserted-by":"publisher","first-page":"e1008850","DOI":"10.1371\/journal.ppat.1008850","volume":"16","author":"N Freitas","year":"2020","unstructured":"Freitas, N. et al. The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity. PLOS Pathog. 16, e1008850 (2020).","journal-title":"PLOS Pathog."},{"key":"34923_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00293-9","volume":"6","author":"JJ Suschak","year":"2021","unstructured":"Suschak, J. J. et al. A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice. NPJ Vaccines 6, 31 (2021).","journal-title":"NPJ Vaccines"},{"key":"34923_CR17","doi-asserted-by":"publisher","unstructured":"Mishra, A. K. et al. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38. J. Virol. 94 https:\/\/doi.org\/10.1128\/jvi.02005-19 (2020).","DOI":"10.1128\/jvi.02005-19"},{"key":"34923_CR18","doi-asserted-by":"publisher","first-page":"e0008637","DOI":"10.1371\/journal.pntd.0008637","volume":"14","author":"RW Cross","year":"2020","unstructured":"Cross, R. W. et al. Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys. PLoS Negl. Trop. Dis. 14, e0008637 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"34923_CR19","doi-asserted-by":"publisher","unstructured":"Haddock, E. et al. A cynomolgus macaque model for Crimean-Congo haemorrhagic fever. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-018-0141-7 (2018).","DOI":"10.1038\/s41564-018-0141-7"},{"key":"34923_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","volume":"6","author":"DW Hawman","year":"2021","unstructured":"Hawman, D. W. et al. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model. Nat. Microbiol. 6, 187\u2013195 (2021).","journal-title":"Nat. Microbiol."},{"key":"34923_CR21","doi-asserted-by":"publisher","first-page":"104858","DOI":"10.1016\/j.antiviral.2020.104858","volume":"181","author":"DW Hawman","year":"2020","unstructured":"Hawman, D. W. et al. Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antivir. Res. 181, 104858 (2020).","journal-title":"Antivir. Res."},{"key":"34923_CR22","doi-asserted-by":"publisher","first-page":"e1008050","DOI":"10.1371\/journal.ppat.1008050","volume":"15","author":"DR Smith","year":"2019","unstructured":"Smith, D. R. et al. Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis. PLoS Pathog. 15, e1008050 (2019).","journal-title":"PLoS Pathog."},{"key":"34923_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99130-1","volume":"11","author":"CE Arnold","year":"2021","unstructured":"Arnold, C. E. et al. Host response transcriptomic analysis of Crimean-Congo hemorrhagic fever pathogenesis in the cynomolgus macaque model. Sci. Rep. 11, 19807 (2021).","journal-title":"Sci. Rep."},{"key":"34923_CR24","doi-asserted-by":"publisher","first-page":"D364","DOI":"10.1093\/nar\/gku1028","volume":"43","author":"WG Touw","year":"2015","unstructured":"Touw, W. G. et al. A series of PDB-related databanks for everyday needs. Nucleic Acids Res. 43, D364\u2013368 (2015).","journal-title":"Nucleic Acids Res."},{"key":"34923_CR25","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/bip.360221211","volume":"22","author":"W Kabsch","year":"1983","unstructured":"Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577\u20132637 (1983).","journal-title":"Biopolymers"},{"key":"34923_CR26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"34923_CR27","doi-asserted-by":"publisher","first-page":"19504","DOI":"10.2807\/ese.15.10.19504-en","volume":"15","author":"HC Maltezou","year":"2010","unstructured":"Maltezou, H. C. et al. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Eur. Surveill.: Bull. Eur.\u00e9en. sur les. maladies transmissibles = Eur. communicable Dis. Bull. 15, 19504 (2010).","journal-title":"Eur. Surveill.: Bull. Eur.\u00e9en. sur les. maladies transmissibles = Eur. communicable Dis. Bull."},{"key":"34923_CR28","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/S0140-6736(12)62097-2","volume":"380","author":"TK Burki","year":"2012","unstructured":"Burki, T. K. Ticks and Turkey. Lancet 380, 1897\u20131898 (2012).","journal-title":"Lancet"},{"key":"34923_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.meegid.2017.04.017","volume":"52","author":"O Orkun","year":"2017","unstructured":"Orkun, O., Karaer, Z., Cakmak, A. & Nalbantoglu, S. Crimean-Congo hemorrhagic fever virus in ticks in Turkey: A broad range tick surveillance study. Infect. Genet. Evol. 52, 59\u201366 (2017).","journal-title":"Infect. Genet. Evol."},{"key":"34923_CR30","doi-asserted-by":"publisher","unstructured":"Mehmood, Q., Tahir, M. J., Jabbar, A., Siddiqi, A. R. & Ullah, I. Crimean-Congo hemorrhagic fever outbreak in Turkey amid the coronavirus disease 2019 (COVID-19) pandemic; a debacle for the healthcare system of Turkey. Infect. Control Hosp. Epidemiol. 1\u20132, https:\/\/doi.org\/10.1017\/ice.2021.343 (2021).","DOI":"10.1017\/ice.2021.343"},{"key":"34923_CR31","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.cell.2018.03.061","volume":"173","author":"MM Sajadi","year":"2018","unstructured":"Sajadi, M. M. et al. Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses. Cell 173, 1783\u20131795 e1714 (2018).","journal-title":"Cell"},{"key":"34923_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","volume":"28","author":"MM Sauer","year":"2021","unstructured":"Sauer, M. M. et al. Structural basis for broad coronavirus neutralization. Nat. Struct. Mol. Biol. 28, 478\u2013486 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"34923_CR33","doi-asserted-by":"publisher","first-page":"752003","DOI":"10.3389\/fimmu.2021.752003","volume":"12","author":"LB Shrestha","year":"2021","unstructured":"Shrestha, L. B., Tedla, N. & Bull, R. A. Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants. Front. Immunol. 12, 752003 (2021).","journal-title":"Front. Immunol."},{"key":"34923_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682\u2013687 (2020).","journal-title":"Nature"},{"key":"34923_CR35","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","volume":"174","author":"EO Saphire","year":"2018","unstructured":"Saphire, E. O. et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell 174, 938\u2013952.e913 (2018).","journal-title":"Cell"},{"key":"34923_CR36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/infdis\/jiz657","volume":"223","author":"HR Wagstaffe","year":"2021","unstructured":"Wagstaffe, H. R. et al. Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination. J. Infect. Dis. 223, 1171\u20131182 (2021).","journal-title":"J. Infect. Dis."},{"key":"34923_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06741-w","volume":"9","author":"T Abreu-Mota","year":"2018","unstructured":"Abreu-Mota, T. et al. Non-neutralizing antibodies elicited by recombinant Lassa\u2013Rabies vaccine are critical for protection against Lassa fever. Nat. Commun. 9, 4223 (2018).","journal-title":"Nat. Commun."},{"key":"34923_CR38","doi-asserted-by":"publisher","unstructured":"Foster Stephanie, L. et al. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proc. Natl Acad. Sci. 119, e2200065119 https:\/\/doi.org\/10.1073\/pnas.2200065119 (2022).","DOI":"10.1073\/pnas.2200065119"},{"key":"34923_CR39","doi-asserted-by":"publisher","first-page":"108962","DOI":"10.1016\/j.celrep.2021.108962","volume":"35","author":"JT Earnest","year":"2021","unstructured":"Earnest, J. T. et al. The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies. Cell Rep. 35, 108962 (2021).","journal-title":"Cell Rep."},{"key":"34923_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00819-y","volume":"18","author":"WD Tolbert","year":"2020","unstructured":"Tolbert, W. D. et al. Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site. BMC Biol. 18, 91 (2020).","journal-title":"BMC Biol."},{"key":"34923_CR41","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","volume":"292","author":"M Lo","year":"2017","unstructured":"Lo, M. et al. Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice*. J. Biol. Chem. 292, 3900\u20133908 (2017).","journal-title":"J. Biol. Chem."},{"key":"34923_CR42","doi-asserted-by":"publisher","first-page":"e1004879","DOI":"10.1371\/journal.ppat.1004879","volume":"11","author":"\u00c9 Bergeron","year":"2015","unstructured":"Bergeron, \u00c9. et al. Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin. PLOS Pathog. 11, e1004879 (2015).","journal-title":"PLOS Pathog."},{"key":"34923_CR43","doi-asserted-by":"publisher","first-page":"15214","DOI":"10.1073\/pnas.1407087111","volume":"111","author":"JK Millet","year":"2014","unstructured":"Millet, J. K. & Whittaker, G. R. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc. Natl Acad. Sci. 111, 15214\u201315219 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"34923_CR44","doi-asserted-by":"publisher","first-page":"eabe4507","DOI":"10.1126\/sciadv.abe4507","volume":"7","author":"ND Newton","year":"2021","unstructured":"Newton, N. D. et al. The structure of an infectious immature flavivirus redefines viral architecture and maturation. Sci. Adv. 7, eabe4507 (2021).","journal-title":"Sci. Adv."},{"key":"34923_CR45","doi-asserted-by":"publisher","first-page":"e1004461","DOI":"10.1371\/journal.ppat.1004461","volume":"10","author":"EM Scherer","year":"2014","unstructured":"Scherer, E. M. et al. Characteristics of Memory B Cells Elicited by a Highly Efficacious HPV Vaccine in Subjects with No Pre-existing Immunity. PLOS Pathog. 10, e1004461 (2014).","journal-title":"PLOS Pathog."},{"key":"34923_CR46","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.1128\/JVI.00426-12","volume":"86","author":"MA Moody","year":"2012","unstructured":"Moody, M. A. et al. HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages. J. Virol. 86, 7496\u20137507 (2012).","journal-title":"J. Virol."},{"key":"34923_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature12966","volume":"507","author":"BE Correia","year":"2014","unstructured":"Correia, B. E. et al. Proof of principle for epitope-focused vaccine design. Nature 507, 201\u2013206 (2014).","journal-title":"Nature"},{"key":"34923_CR48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.nano.2015.11.007","volume":"12","author":"YN Lee","year":"2016","unstructured":"Lee, Y. N. et al. Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin. Nanomedicine 12, 759\u2013770 (2016).","journal-title":"Nanomedicine"},{"key":"34923_CR49","doi-asserted-by":"publisher","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","volume":"45","author":"S Bienert","year":"2017","unstructured":"Bienert, S. et al. The SWISS-MODEL Repository\u2014new features and functionality. Nucleic Acids Res. 45, D313\u2013D319 (2017).","journal-title":"Nucleic Acids Res."},{"key":"34923_CR50","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"34923_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09654-8","volume":"7","author":"M Bertoni","year":"2017","unstructured":"Bertoni, M., Kiefer, F., Biasini, M., Bordoli, L. & Schwede, T. Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology. Sci. Rep. 7, 10480 (2017).","journal-title":"Sci. Rep."},{"key":"34923_CR52","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","volume":"30","author":"N Guex","year":"2009","unstructured":"Guex, N., Peitsch, M. C. & Schwede, T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective. ELECTROPHORESIS 30, S162\u2013S173 (2009).","journal-title":"ELECTROPHORESIS"},{"key":"34923_CR53","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","volume":"36","author":"G Studer","year":"2019","unstructured":"Studer, G. et al. QMEANDisCo\u2014distance constraints applied on model quality estimation. Bioinformatics 36, 1765\u20131771 (2019).","journal-title":"Bioinformatics"},{"key":"34923_CR54","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779\u2013815 (1993).","journal-title":"J. Mol. Biol."},{"key":"34923_CR55","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. Sect. D. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. Sect. D."},{"key":"34923_CR56","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"34923_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.antiviral.2017.10.008","volume":"147","author":"SR Welch","year":"2017","unstructured":"Welch, S. R. et al. Identification of 2\u2032-deoxy-2\u2032-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. Antivir. Res. 147, 91\u201399 (2017).","journal-title":"Antivir. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34923-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34923-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34923-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T01:22:28Z","timestamp":1669771348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34923-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34923"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34923-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1777816\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]},"assertion":[{"value":"1 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R.G. and J.W.G. are inventors on a patent application related to the use of mAb 13G8 as a therapeutic, PCT\/US2020\/012621. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7298"}}